In light to our results that show the association of SIRT-3 and p-mTOR with metabolic etiology and presence of T2DM, we verified whether the expression of the markers was related to the presence of HCC or metabolic dysfunctions. The gene discussed is MTOR; the disease is hepatocellular carcinoma.